Get started
Author

Michael Taylor

Observed name: M. Taylor
ORCID: 0000-0003-1115-5449
Observed ORCID: 0000-0003-1115-5449
OpenAlex ID: A5000640064
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2023 · Catherine Dietrich, Alec Trub, et al. · Cancer Discovery · 130
PDF
Future directions in advanced penile cancer – mechanisms of carcinogenesis and a search for targeted therapy
2020 · Jiasian Teh, Ellen O’Connor, et al. · Future Oncology · 9
Abstract 5994: INX-315, a potent and selective CDK2 inhibitor, demonstrates robust antitumor activity in CCNE1-amplified cancers
2023 · Alec G. Trub, John E. Bisi, et al. · Cancer Research · 4
Data from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al. · 3
Rb-driven transcription limits its tumour-suppressive effects in breast cancer
2026 · April C. Watt, Antonio Ahn, et al. · Nature · 2
Correction: INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025 · Catherine Dietrich, Alec Trub, et al. · Cancer Discovery · 2
PDF
Supplementary Synthetic Methods from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al. · 1
Abstract GS3-06: Rb Functions as a Transcriptional Activator of ER Targets Following CDK4/6 Inhibition in Luminal Breast Cancer
2026 · A. C. Watt, A. Ahn, et al. · Clinical Cancer Research
Supplementary Table 1 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025 · Catherine Dietrich, Alec Trub, et al.
Supplementary Table 2 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025 · Catherine Dietrich, Alec Trub, et al.
Supplementary Figures 1-14 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025 · Catherine Dietrich, Alec Trub, et al.
PDF
Supplementary Synthetic Methods from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025 · Catherine Dietrich, Alec Trub, et al.
PDF
Figure 6 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Figure 3 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Figure 1 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Supplementary Table 2 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Figure 6 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Supplementary Figures 1-14 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
PDF
Figure 5 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Figure 5 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Data from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Supplementary Figures 1-14 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Supplementary Table 1 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Figure 3 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Figure 1 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024 · Catherine Dietrich, Alec Trub, et al.
Works count: 33
Citation count: 150
H-index: 3
I10-index: 1
Year
Topic
Type